Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride, a hair loss drug, may cause sexual dysfunction and depression, but these effects are usually temporary and the drug is generally safe. More research is needed.

Alopecia areata is rare in organ transplant patients and may be linked to the drug tacrolimus.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Minoxidil improves blood flow and vessel flexibility, potentially helping with vascular stiffness.

Cosmeceuticals may have potential but their effectiveness and market success are still uncertain.

The document concludes that it's important to understand the placebo effect when evaluating the effectiveness of treatments in medical trials.

Finasteride use linked to increased risk of sexual dysfunction, especially in younger people.

Minoxidil lowers blood pressure and causes hair growth, with some side effects.

Minoxidil effectively treats severe hypertension but has notable side effects.

5α-reductase inhibitors like finasteride may not be effective or safe for transgender individuals, and more research is needed.

Finasteride may cause kidney damage.

Myotonic dystrophy should be considered in patients with hair thinning, and genetic counseling is important.

Myotonic Dystrophy may age cells faster, and drugs that target aging could be potential treatments.

Eating shiitake mushrooms caused a man to develop a rash similar to a skin condition known as AGEP.

The Mediterranean dwarf palm has medicinal, nutritional, and craft uses, but more research is needed.

Future treatments for androgenic alopecia may focus on reactivating hair follicle stem cells and improving drug delivery.

AI can improve early diagnosis and treatment of diabetic foot complications but requires addressing training and ethical challenges.

Stress, hypothyroidism, drug intake, and anemia are important factors in women's diffuse hair loss.

Women with PCOS have higher risks of heart disease, type 2 diabetes, and endometrial cancer.

Ginsenoside compound K shows promise for treating metabolic diseases like obesity and diabetes, but more research is needed on its safety and effectiveness.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

Physalis fruits have medicinal properties that can help treat various diseases and have anti-inflammatory, antioxidant, antibacterial, and antitumor effects.

A 60-year-old man with a long-term balding condition also developed a rare hair loss condition usually seen in postmenopausal women.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Early hair loss may indicate risk of insulin resistance.

Neuroactive steroids affect cocaine's rewarding effects through the ς₁ receptor.

Photothermal hydrogels are promising for infection control and tissue repair, and combining them with other treatments could improve results and lower costs.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

Flutamide reduces hair growth better but has more side effects.